Investment House LLC boosted its position in Henry Schein Inc. (NASDAQ:HSIC) by 5.5% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 22,090 shares of the company’s stock after buying an additional 1,150 shares during the period. Investment House LLC’s holdings in Henry Schein were worth $3,906,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. Three Peaks Capital Management LLC purchased a new stake in Henry Schein during the first quarter worth $4,950,000. Virginia Retirement System purchased a new stake in Henry Schein during the first quarter worth $32,290,000. Buffington Mohr McNeal increased its stake in Henry Schein by 29.0% in the first quarter. Buffington Mohr McNeal now owns 8,710 shares of the company’s stock worth $1,504,000 after buying an additional 1,960 shares during the period. Mn Services Vermogensbeheer B.V. purchased a new stake in Henry Schein during the first quarter worth $313,000. Finally, Aperio Group LLC increased its stake in Henry Schein by 2.9% in the first quarter. Aperio Group LLC now owns 55,729 shares of the company’s stock worth $9,620,000 after buying an additional 1,581 shares during the period. 92.00% of the stock is currently owned by institutional investors and hedge funds.

Henry Schein Inc. (NASDAQ:HSIC) traded up 0.20% during midday trading on Tuesday, reaching $162.80. The company’s stock had a trading volume of 308,897 shares. The firm has a market cap of $13.32 billion, a P/E ratio of 27.58 and a beta of 1.03. The firm has a 50 day moving average price of $164.07 and a 200-day moving average price of $170.93. Henry Schein Inc. has a 52 week low of $127.16 and a 52 week high of $183.00.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Thursday, August 4th. The company reported $1.64 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.63 by $0.01. Henry Schein had a net margin of 4.42% and a return on equity of 17.84%. The company had revenue of $2.87 billion for the quarter, compared to analysts’ expectations of $2.85 billion. During the same period last year, the firm earned $1.46 earnings per share. The business’s revenue for the quarter was up 9.3% on a year-over-year basis. On average, analysts forecast that Henry Schein Inc. will post $6.57 earnings per share for the current fiscal year.

A number of equities research analysts recently weighed in on the company. Zacks Investment Research downgraded Henry Schein from a “buy” rating to a “hold” rating in a research report on Tuesday, July 5th. Credit Suisse Group AG reissued a “hold” rating on shares of Henry Schein in a research report on Saturday, June 4th. Finally, Bank of America Corp. assumed coverage on Henry Schein in a research report on Monday, September 12th. They set a “buy” rating and a $185.00 target price on the stock. One research analyst has rated the stock with a sell rating, six have issued a hold rating and four have given a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average price target of $157.84.

In other news, Director Paul Brons sold 3,381 shares of the firm’s stock in a transaction that occurred on Monday, August 29th. The shares were sold at an average price of $164.03, for a total transaction of $554,585.43. Following the transaction, the director now directly owns 13,715 shares of the company’s stock, valued at $2,249,671.45. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 1.27% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc is a provider of health care products and services to office-based dental, animal health and medical practitioners. The Company’s segments include healthcare distribution, and technology and value-added services. The healthcare distribution segment aggregates its global dental, animal health and medical operating segments.

5 Day Chart for NASDAQ:HSIC

Want to see what other hedge funds are holding HSIC? Visit to get the latest 13F filings and insider trades for Henry Schein Inc. (NASDAQ:HSIC).

Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with's FREE daily email newsletter.